# FDA Inspection 1202268 - CSL Behring L.L.C. - March 02, 2023

Source: https://www.keypedia.com/records/fda_inspections/csl-behring-llc/ef49327a-c2e6-486f-be49-cd85f5b500f8
Source feed: FDA_Inspections

> FDA Inspection 1202268 for CSL Behring L.L.C. on March 02, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202268
- Company Name: CSL Behring L.L.C.
- Inspection Date: 2023-03-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1153026 - 2021-09-24](https://www.keypedia.com/records/fda_inspections/csl-behring-llc/73edec5f-829f-4080-8d43-295eb32e9367)
- [FDA Inspection 1153026 - 2021-09-24](https://www.keypedia.com/records/fda_inspections/csl-behring-llc/3bcb3c6c-e138-4d12-b6e5-b74b2c21d4ff)
- [FDA Inspection 1090775 - 2019-05-23](https://www.keypedia.com/records/fda_inspections/csl-behring-llc/e08a34df-b1ea-4be0-8656-604507a418bc)
- [FDA Inspection 1090775 - 2019-05-23](https://www.keypedia.com/records/fda_inspections/csl-behring-llc/00041219-24a4-4705-b67e-a337a00921e3)
- [FDA Inspection 1072948 - 2018-10-18](https://www.keypedia.com/records/fda_inspections/csl-behring-llc/979a066e-2954-4ce6-b65d-a34872280418)

Company: https://www.keypedia.com/companies/csl-behring-llc/bb057a50-8ebe-4207-b535-b5ecc4b342d9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d